share_log

石四药集团(02005.HK)获China Pharmaceutical Company Limited增持80万股普通股股份,价值约381.04万港元

Shisi Pharmaceutical Group (02005.HK) received 800,000 additional shares of common stock worth approximately HK$3,810,400 from China Pharmaceutical Company Limited

Futu News ·  Apr 17 17:04

On April 17, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 17, China Pharmaceutical Company Limited increased its holdings at an average price of HK$4.763 per share on April 17$SSY GROUP (02005.HK)$800,000 common shares worth approximately HK$3,810,400. After the increase in holdings, China Pharmaceutical Company Limited's latest shareholding was 832 million shares, and the good position ratio rose from 27.98% to 28.01%.

HKEXAutoNews_CS20240417E00337.png

What is disclosure of interests?

As required by the Hong Kong Stock Exchange, major shareholders (individuals and companies holding 5% or more of the shares) are required to disclose their share interests in listed companies. The directors and top executives of a listed company must disclose their interest in shares and debentures of the listed company and the company linked to the listed company.

Why is disclosure of interests important?

Disclosure of interests allows investors to identify (1) persons who control or are capable of controlling the stock interests of listed companies, and (2) persons who may benefit from transactions involving linked entities of listed companies.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment